HomeAARD • NASDAQ
add
Aardvark Therapeutics Inc
Previous close
$10.01
Day range
$9.67 - $10.81
Year range
$4.88 - $19.58
Market cap
227.81M USD
Avg Volume
62.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.47M | 154.00% |
Net income | -9.31M | -144.13% |
Net profit margin | — | — |
Earnings per share | -0.71 | — |
EBITDA | -10.47M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 151.26M | 75.18% |
Total assets | 157.02M | 80.07% |
Total liabilities | 6.34M | 137.93% |
Total equity | 150.69M | — |
Shares outstanding | 13.19M | — |
Price to book | 0.88 | — |
Return on assets | -22.32% | — |
Return on capital | -23.34% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -9.31M | -144.13% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2017
Website
Employees
22
